The ASX 200 staged a risk-on comeback Friday, with materials and base-metal plays surging whilst high-multiple healthcare and technology names pulled back ahead of the weekend.
The S&P/ASX 200 closed 0.5% higher at 8,806, reclaiming the psychologically important 8,800 level after a volatile week that saw the index ultimately fall back 0.43%. The ASX All Ords closed up 0.47% at 9,003.70, down 0.5% on the week, as the mild underperformance to the bluechip index continued.
ASX Today: Materials Lead
The day’s gains at an index level were driven by a powerful 2.32% rally in the Materials sector, supported by a 0.55% gain in Financials, even as Industrials slipped 0.39% and Energy dipped 0.22%.
Leading the charge was biotech Mesoblast, which surged 6.67% to $2.24, extending a strong run fuelled by growing commercial revenues and advancing late-stage cell-therapy programmes. The company’s rexlemestrocel-L pipeline for back pain and inflammatory conditions has drawn renewed attention from markets seeking visible catalysts in the healthcare space.
Capstone Copper shares climbed 6.45% to $13.04, bouncing back after a 20% sell-off over recent weeks. Similarly, diversified miner South32 jumped 5.24% to $4.02, reflecting broad-based strength across aluminium, manganese and base-metal exposures as markets dialled back concerns over Chinese growth and global demand.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Gold miners Resolute Mining and Ora Banda Mining rebounded sharply, rising 5.56% to $0.95 and 5.16% to $1.12 respectively, after being hammered in recent sessions as bullion sold off on higher-for-longer rate fears.
Index Laggards
At the other end of the spectrum, healthcare IT leader Pro Medicus shares tumbled 6.34% to $197.07 in a move that appeared driven by valuation after a 100% bounce off the lows.
Defence technology name Electro Optic Systems fell 6.24% to $8.41, Telix Pharmaceuticals declined 3.96% to $16.27, with Elsight dropping 3.61% to $7.74, Codan falling 2.68% to $43.30, and Brambles declining 2.65% to $18.74. Olive oil producer Cobram Estate Olives slipped 2.67% to $3.65 to round out the laggards.
What Lay Ahead
Technical factors also played a role, with the ASX 200’s reclaim of 8,800 providing a psychological boost that encouraged risk-taking in beaten-down cyclicals. Yet the index’s modest weekly decline of 0.43% and recent history of sharp intraday reversals suggest underlying caution persists. Recent sessions have seen violent moves in both directions, with oil-driven sell-offs and gold-miner routs demonstrating how quickly macro headlines can take the fore.
Looking ahead, the sustainability of Friday’s cyclical rally will depend on whether commodity prices and base-metal demand can hold current levels, and whether growth concerns around China and global trade moderate. For the gold miners, further gains hinge on bullion stabilising and real yields retreating, both of which remain uncertain given ongoing debates over inflation persistence and central-bank policy paths.
The session offered a textbook example of factor rotation in action, with cyclical value outperforming growth and quality in a risk-on environment. Yet the speed and magnitude of moves in both directions serve as a reminder that conviction remains thin, and that markets are trading headlines and positioning as much as fundamentals.
Bull Case:
- Materials rally signals renewed confidence in commodity demand and China stabilisation
- Copper exposure offers structural upside from electrification and infrastructure investment themes
- Gold miner bounce creates tactical opportunity after severe oversold conditions and capitulation
Bear Case:
- High-multiple growth names face persistent valuation pressure and factor headwinds
- Cyclical rally vulnerable to quick reversal on macro headlines or commodity price weakness
- Recent volatility and thin conviction suggest positioning-driven moves rather than durable trend
